Skip to main content

Common entrance exam now first stage of Agniveer selection from this year

To keep you updated, we send Defence News to your mailbox. In case, you wish to Unsubscribe Click Here
The Economic Times

Defence News


Dear Reader,

Just catching up? Here are the top defence stories from the day...
Common entrance exam now first stage of Agniveer Selection from this yearCommon entrance exam now first stage of Agniveer Selection from this year
The Director Recruiting at Army Recruiting Office, Secunderabad, Colonel Keats K Das, on Tuesday gave a brief with regard to the conduct of Agniveer Selection for the year 2023-24, saying that the recruitment rally will be conducted in three stages. Read more
Killers of Kashmiri Pandit guard gunned down in Pulwama, Army jawan also killedKillers of Kashmiri Pandit guard gunned down in Pulwama, Army jawan also killed
An Army jawan was also killed. Security forces cordoned off an area in Padgampora village following a tip-off that at least two armed terrorists were hiding inside the mosque, officials said. The incident, which comes after Sunday's killing of a Kashmiri Pandit, took place around 1.15 am. Read more
Fiji pivots away from China signalling Beijing's declining influence in South PacificFiji pivots away from China signalling Beijing's declining influence in South Pacific
Along with dismissing Qiliho, the Fijian government led by new Prime Minister Sitiveni Rabuka Rabuka also scrapped the Memorandum of Understanding (MoU) for police training and exchange between the Fiji Police Force and the Ministry of Public Security of China, according to a report in local daily Fiji Times. Read more
Moscow says Ukraine launched failed drone attacks on Russian territory overnightMoscow says Ukraine launched failed drone attacks on Russian territory overnight
"Overnight, the Kyiv authorities attempted to use unmanned aerial vehicles to attack civilian infrastructure facilities in the Krasnodar and Adygea regions," the defence ministry said in a statement. Read more
US lawmaker warns India against Chinese-tainted Russian weaponsUS lawmaker warns India against Chinese-tainted Russian weapons
As India and the US have deepened and broadened defence cooperation, with Indian purchases of American military hardware at an all-time high, Washington DC has had concerns that its sensitive-technology military hardware sold to India can be accessed by Russia through their equipment that flood Indian armories. This has been cited as a chief concern by Americans as they press India, without success, to cancel its order of the Russian S-400 air missile defence system. They also say that the presence of Russian equipment impeded interoperability between the militaries of India and the US. Read more
India-Japan step up military partnership amid China's belligerenceIndia-Japan step up military partnership amid China's belligerence
While the 4th edition of joint military exercise, 'Dharma Guardian', is being conducted at Camp Imazu in Shiga province of Japan from February 17 to March 2, the Air Self-Defense Force (ASDF) will conduct joint transport exercise, 'Shinyu Maitri 23', with the Indian Air Force on March 1-2. Read more
Supreme Court raps Ministry of Defence over payment of arrears of OROP in installmentsSupreme Court raps Ministry of Defence over payment of arrears of OROP in installments
"You tell the secretary we are going to take action against him for that January 20 communication. Either withdraw it, or we are going to issue a contempt notice to the Ministry of Defense. Sanctity of the judicial process has to be maintained," the bench also comprising Justices PS Narasimha and JB Pardiwala said. Read more
Southern Naval Command celebrates 36 years of Navy ship's service with cycling tripSouthern Naval Command celebrates 36 years of Navy ship's service with cycling trip
"A total of 36 cyclists including four army personnel from 91 Infantry Brigade took part in the expedition which covered a total distance of approximately 500 kms in five days," the Navy said in a release. Read more
Indian Navy's aircraft carrier INS Vikramaditya carrying out sea trials post-refitIndian Navy's aircraft carrier INS Vikramaditya carrying out sea trials post-refit
At present, India has two aircraft carriers -- INS Vikramaditya and INS Viraat, while it is planning to develop a third -- INS Vishaal by 2030. Read more
US Treasury Secretary Janet Yellen visits Ukraine, underscores US economic supportUS Treasury Secretary Janet Yellen visits Ukraine, underscores US economic support
Yellen said following talks with Ukrainian Prime Minister Denys Shmyhal that the US has provided nearly USD 50 billion in security, economic and humanitarian assistance and announced another multibillion dollar package to boost the country's economy. Read more
Thanks for reading. Follow us on Twitter and Facebook.

Did you like today's newsletter?

hate it love it

Comments

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr

Israel activates evacuation plan for 28 communities along Lebanon border

To keep you updated, we send Defence News to your mailbox. In case, you wish to Unsubscribe Click Here Defence News Dear Reader, Just catching up? Here are the top